Article
Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions.
Pharmacogenetics and genomics - 1 Aug 2015
Kongpan Thachanan, Mahasirimongkol Surakameth, Konyoung Parinya, Kanjanawart Sirimas, Chumworathayi Pansu, Wichukchinda Nuanjun, Kidkeukarun Runglak, Preechakul Suphanlinee, Khunarkornsiri Usanee, Bamrungram Warawut, Supharatwattanakun Butsaban, Mootsikapun Piroon, Kwangsukstid Supanida, Denjanta Sukanda, Vannaprasaht Suda, Rungapiromnan Watcharee, Suwankesawong Wimon, Tassaneeyakul Wongwiwat, Tassaneeyakul Wichittra
Abstract excerpt
BACKGROUND: Co-trimoxazole is a sulfonamide-containing antibiotic that is effective in the treatment of several infections and for prophylaxis of Pneumocystis jiroveci pneumonia. This drug has been reported as a common culprit drug for the Stevens-Johnson syndrome (SJS) and for toxic epidermal necrolysis (TEN). Human leukocyte antigens (HLAs) play a key role in the immunopathogenesis of severe cutaneous reactions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
